Skip to main content
Erschienen in: Surgical Endoscopy 8/2020

07.10.2019 | Surgery

Conversion to open surgery during minimally invasive esophagectomy portends worse short-term outcomes: an analysis of the National Cancer Database

verfasst von: Alison L. Halpern, Chloe Friedman, Robert J. Torphy, Mohammed H. Al-Musawi, John D. Mitchell, Christopher D. Scott, Robert A. Meguid, Martin D. McCarter, Michael J. Weyant, Ana L. Gleisner

Erschienen in: Surgical Endoscopy | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objectives were to determine factors associated with conversion to open surgery in patients with esophageal cancer who underwent minimally invasive esophagectomy (MIE, including laparo-thoracoscopic and robotic) and the impact of conversion to open surgery on patient outcomes.

Methods

We included patients from the National Cancer Database with esophageal and gastroesophageal junction cancer who underwent MIE from 2010 to 2015. Patient-, tumor-, and facility-related characteristics as well as short-term and oncologic outcomes were compared between patients who were converted to open surgery and those who underwent successful MIE without conversion to open surgery. Multivariable logistic regression models were used to analyze risk factors for conversion to open surgery from attempted MIE.

Results

7306 patients underwent attempted MIE. Of these patients, 82 of 1487 (5.2%) robotic-assisted esophagectomies were converted to open, compared to 691 of 5737 (12.0%) laparo-thoracoscopic esophagectomies (p < 0.001). Conversion rates decreased significantly over the study period (ptrend = 0.010). Patient age, tumor size, and nodal involvement were independently associated with conversion. Facility minimally invasive cumulative volume and robotic approach were associated with decreased conversion rates. Patients whose MIEs were converted had increased 90-day mortality [Odds Ratio (OR) 1.49; 95% Confidence Interval (CI) 1.10, 2.02], prolonged hospital stay (OR 1.39; 95% CI 1.17, 1.66), and higher rates of unplanned readmission (OR 1.67; 95% CI 1.27, 2.20). No significant differences were found in surgical margins or number of lymph nodes harvested.

Conclusion

Patients undergoing attempted MIE requiring conversion to open surgery had significantly worse short-term outcomes including postoperative mortality. Patient factors and hospital experience contribute to conversion rates. These findings should inform surgeons and patients considering esophagectomy for cancer.
Literatur
1.
Zurück zum Zitat Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomark Prev 25:16–27CrossRef Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomark Prev 25:16–27CrossRef
2.
Zurück zum Zitat Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef
3.
Zurück zum Zitat National Comprehensive Cancer Network Esophageal and Esophagogastric Junction Cancers (2018) National Comprehensive Cancer Network Esophageal and Esophagogastric Junction Cancers (2018)
4.
Zurück zum Zitat Bhagat R, Bronsert MR, Juarez-Colunga E et al (2018) Postoperative complications drive unplanned readmissions after esophagectomy for cancer. Ann Thorac Surg 105:1476–1482CrossRef Bhagat R, Bronsert MR, Juarez-Colunga E et al (2018) Postoperative complications drive unplanned readmissions after esophagectomy for cancer. Ann Thorac Surg 105:1476–1482CrossRef
5.
Zurück zum Zitat Thirunavukarasu P, Gabriel E, Attwood K et al (2016) Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy. Int J Surg 25:69–75CrossRef Thirunavukarasu P, Gabriel E, Attwood K et al (2016) Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy. Int J Surg 25:69–75CrossRef
6.
Zurück zum Zitat Sihag S, Kosinski AS, Gaissert HA et al (2016) Minimally invasive versus open esophagectomy for esophageal cancer: A comparison of early surgical outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 101:1281–1288 (Discussion 1288–1289) CrossRef Sihag S, Kosinski AS, Gaissert HA et al (2016) Minimally invasive versus open esophagectomy for esophageal cancer: A comparison of early surgical outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 101:1281–1288 (Discussion 1288–1289) CrossRef
7.
Zurück zum Zitat Seesing MFJ, Gisbertz SS, Goense L et al (2017) A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands. Ann Surg 266:839–846CrossRef Seesing MFJ, Gisbertz SS, Goense L et al (2017) A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands. Ann Surg 266:839–846CrossRef
8.
Zurück zum Zitat Luketich JD, Pennathur A, Awais O et al (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256:95–103CrossRef Luketich JD, Pennathur A, Awais O et al (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256:95–103CrossRef
9.
Zurück zum Zitat Mu JW, Gao SG, Xue Q et al (2015) Updated experiences with minimally invasive McKeown esophagectomy for esophageal cancer. World J Gastroenterol 21:12873–12881CrossRef Mu JW, Gao SG, Xue Q et al (2015) Updated experiences with minimally invasive McKeown esophagectomy for esophageal cancer. World J Gastroenterol 21:12873–12881CrossRef
10.
Zurück zum Zitat Luketich JD, Pennathur A, Franchetti Y et al (2015) Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg 261:702–707CrossRef Luketich JD, Pennathur A, Franchetti Y et al (2015) Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg 261:702–707CrossRef
11.
Zurück zum Zitat He H, Wu Q, Wang Z et al (2018) Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer: a propensity score matched analysis. J Cardiothorac Surg 13:52CrossRef He H, Wu Q, Wang Z et al (2018) Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer: a propensity score matched analysis. J Cardiothorac Surg 13:52CrossRef
12.
Zurück zum Zitat Yerokun BA, Sun Z, Yang CJ et al (2016) Minimally invasive versus open esophagectomy for esophageal cancer: a population-based analysis. Ann Thorac Surg 102:416–423CrossRef Yerokun BA, Sun Z, Yang CJ et al (2016) Minimally invasive versus open esophagectomy for esophageal cancer: a population-based analysis. Ann Thorac Surg 102:416–423CrossRef
13.
Zurück zum Zitat Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892CrossRef Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892CrossRef
14.
Zurück zum Zitat Mariette C, Markar SR, Dabakuyo-Yonli TS et al (2019) Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med 380:152–162CrossRef Mariette C, Markar SR, Dabakuyo-Yonli TS et al (2019) Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med 380:152–162CrossRef
15.
Zurück zum Zitat Straatman J, van der Wielen N, Cuesta MA et al (2017) Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg 266:232–236CrossRef Straatman J, van der Wielen N, Cuesta MA et al (2017) Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg 266:232–236CrossRef
16.
Zurück zum Zitat Weksler B, Sharma P, Moudgill N et al (2012) Robot-assisted minimally invasive esophagectomy is equivalent to thoracoscopic minimally invasive esophagectomy. Dis Esophagus 25:403–409CrossRef Weksler B, Sharma P, Moudgill N et al (2012) Robot-assisted minimally invasive esophagectomy is equivalent to thoracoscopic minimally invasive esophagectomy. Dis Esophagus 25:403–409CrossRef
17.
Zurück zum Zitat Park SY, Kim DJ, Yu WS, Jung HS (2016) Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer. Dis Esophagus 29:326–332CrossRef Park SY, Kim DJ, Yu WS, Jung HS (2016) Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer. Dis Esophagus 29:326–332CrossRef
18.
Zurück zum Zitat Dunn DH, Johnson EM, Anderson CA et al (2017) Operative and survival outcomes in a series of 100 consecutive cases of robot-assisted transhiatal esophagectomies. Dis Esophagus 30:1–7CrossRef Dunn DH, Johnson EM, Anderson CA et al (2017) Operative and survival outcomes in a series of 100 consecutive cases of robot-assisted transhiatal esophagectomies. Dis Esophagus 30:1–7CrossRef
19.
Zurück zum Zitat Biebl M, Andreou A, Chopra S et al (2018) Upper gastrointestinal surgery: robotic surgery versus laparoscopic procedures for esophageal malignancy. Visc Med 34:10–15CrossRef Biebl M, Andreou A, Chopra S et al (2018) Upper gastrointestinal surgery: robotic surgery versus laparoscopic procedures for esophageal malignancy. Visc Med 34:10–15CrossRef
20.
Zurück zum Zitat Coker AM, Barajas-Gamboa JS, Cheverie J et al (2014) Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation. J Laparoendosc Adv Surg Tech A 24:89–94CrossRef Coker AM, Barajas-Gamboa JS, Cheverie J et al (2014) Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation. J Laparoendosc Adv Surg Tech A 24:89–94CrossRef
21.
Zurück zum Zitat Tapias LF, Morse CR (2014) Minimally invasive Ivor Lewis esophagectomy: description of a learning curve. J Am Coll Surg 218:1130–1140CrossRef Tapias LF, Morse CR (2014) Minimally invasive Ivor Lewis esophagectomy: description of a learning curve. J Am Coll Surg 218:1130–1140CrossRef
22.
Zurück zum Zitat Hernandez JM, Dimou F, Weber J et al (2013) Defining the learning curve for robotic-assisted esophagogastrectomy. J Gastrointest Surg 17:1346–1351CrossRef Hernandez JM, Dimou F, Weber J et al (2013) Defining the learning curve for robotic-assisted esophagogastrectomy. J Gastrointest Surg 17:1346–1351CrossRef
23.
Zurück zum Zitat National Cancer Database (2017) National Cancer Database National Cancer Database (2017) National Cancer Database
24.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRef Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRef
25.
Zurück zum Zitat World Health Organization, Interim Commission of the World Health Organization, High-Level Working Group on the H et al (1976) International classification of diseases for oncology. World Health Organization, Geneva World Health Organization, Interim Commission of the World Health Organization, High-Level Working Group on the H et al (1976) International classification of diseases for oncology. World Health Organization, Geneva
26.
Zurück zum Zitat Birkmeyer JD, Dimick JB (2004) Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. Surgery 135:569–575CrossRef Birkmeyer JD, Dimick JB (2004) Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. Surgery 135:569–575CrossRef
27.
Zurück zum Zitat Chandra V, Nehra D, Parent R et al (2010) A comparison of laparoscopic and robotic assisted suturing performance by experts and novices. Surgery 147:830–839CrossRef Chandra V, Nehra D, Parent R et al (2010) A comparison of laparoscopic and robotic assisted suturing performance by experts and novices. Surgery 147:830–839CrossRef
28.
Zurück zum Zitat Claassen L, van Workum F, Rosman C (2018) Learning curve and postoperative outcomes of minimally invasive esophagectomy. J Thor Dis 11:S777–S785CrossRef Claassen L, van Workum F, Rosman C (2018) Learning curve and postoperative outcomes of minimally invasive esophagectomy. J Thor Dis 11:S777–S785CrossRef
Metadaten
Titel
Conversion to open surgery during minimally invasive esophagectomy portends worse short-term outcomes: an analysis of the National Cancer Database
verfasst von
Alison L. Halpern
Chloe Friedman
Robert J. Torphy
Mohammed H. Al-Musawi
John D. Mitchell
Christopher D. Scott
Robert A. Meguid
Martin D. McCarter
Michael J. Weyant
Ana L. Gleisner
Publikationsdatum
07.10.2019
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 8/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07124-y

Weitere Artikel der Ausgabe 8/2020

Surgical Endoscopy 8/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.